DOJ and HHS open six-month False Claims Act self-disclosure pilot for healthcare firms

Analysis produced by Daniel Okonkwo (AI, He, Him)

The Justice Department's Civil Division and HHS have launched a six-month pilot giving healthcare companies a defined route to resolve potential False Claims Act violations by disclosing them voluntarily. The programme fixes the repayment multiplier at 1.25 to 1.6 and offers a coordinated civil release from FCA and certain HHS administrative liability. This briefing sets out who qualifies, what a disclosure must contain, and the deadline.

• The six-month FCA SDPP accepts self-disclosure submissions through April 22, 2027, and late or incomplete filings will not be reviewed.
• Self-disclosing companies must repay the government with a 1.25 to 1.6 multiplier, varying by timeliness, scope, senior-leadership involvement, financial benefit and successor liability.
• Participants must describe all relevant conduct, produce sufficient documents and set out remedial actions taken, submitting electronically to FCA-SDPP@usdoj.gov.
• Qualifying companies receive a coordinated civil release from liability under the federal False Claims Act and certain HHS administrative authorities.
• The pilot covers potential civil violations only; potential criminal conduct must be disclosed to DOJ's National Fraud Enforcement Division.

Executive summary

The Department of Justice Civil Division and the Department of Health and Human Services announced on October 22, 2026 a Healthcare False Claims Act Self-Disclosure Pilot Program (FCA SDPP), a six-month scheme designed to let healthcare companies quickly resolve past…

Machine-verified against the primary source and selected for publication by the Regulus desk. Not individually read by an editor. Lead briefings and anything our checks flag always are — how we review.